References
- 1
Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge R C, Weintraub B D.
Thyrotropin-secreting pituitary tumors.
Endocr Rev.
1996;
17
610-638
- 2
Bell D S, Ovalle F.
Use of soy protein supplement and resultant need for increased dose of levothyroxine.
Endocr Pract.
2001;
7
193-194
- 3
Brucker-Davis F, Oldfield E H, Skarulis M C, Doppman J L, Weintraub B D.
Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity
and treatment outcome in 25 patients followed at the National Institutes of Health.
J Clin Endocrinol Metab.
1999;
84
476-486
- 4
Calle-Pascual A L, Yuste E, Martin P, Aramendi T, Garcia-Maurino M L, Argente J, Catalan M J,
Uria J, Cabranes J A, Charro A L.
Association of a thyrotropin-secreting pituitary adenoma and a thyroid follicular
carcinoma.
J Endocrinol Invest.
1991;
14
499-502
- 5
Gasparoni P, Rubello D, Persani L, Beck-Peccoz P.
Unusual association between a thyrotropin-secreting pituitary adenoma and a papillary
thyroid carcinoma.
Thyroid.
1998;
8
181-183
- 6
Gessl A, Freissmuth M, Czech T, Matula C, Hainfellner J A, Buchfelder M, Vierhapper H.
Growth Hormone-Prolactin-Thyrotropin-Secreting Pituitary Adenoma in Atypical McCune-Albright
Syndrome with functionally normal Gsα-Protein.
J Clin Endocrinol Metab.
1994;
79
1128-1134
- 7
Kishida M, Otsuka F, Kataoka H, Yokota K, Oishi T, Yamauchi T, Doihara H, Tamiya T,
Mimura Y, Ogura T, Makino H.
Hyperthyroidism in a patient with TSH-producing pituitary adenoma coexisting with
thyroid papillary adenocarcinoma.
Endocr J.
2000;
6
731-738
- 8
Liel Y, Harman-Boehm I, Shany S.
Evidence for a clinically important adverse effect of fiber-enriched diet on the bioavailability
of levothyroxine in adult hypothyroid patients.
J Clin Endocrinol Metab.
1996;
81
857-859
- 9
Lips D J, van Reisen M T, Voigt V, Venekamp W.
Diagnosis and treatment of levothyroxine pseudomalabsorption.
Neth J Med.
2004;
62
114-118
- 10
McDermott J H, Cross A, Walsh C H.
Celiac disease presenting as resistant hypothyroidism.
Thyroid.
2005;
15
386-388
- 11
Ohta S, Nishizawa S, Oki Y, Namba H.
Coexistence of thyrotropin-producing pituitary adenoma with papillary adenocarcinoma
of the thyroid - a case report and surgical strategy.
Pituitary.
2001;
4
271-274
- 12
Osterberg L, Blaschke T.
Adherence to medication.
New Engl J Med.
2005;
353
487-497
- 13
Pujol B, Daures J P, Nsakala N, Baldet L, Bringer J, Affiol C.
Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid
carcinoma.
J Clin Endocrinol Metab.
1996;
81
4318-4340
- 14
Refetoff S, Weiss R E, Usala S J.
The syndrome of resistance to thyroid hormone.
Endocr Rev.
1993;
14
348-399
- 15
Siraj E S, Gupta M K, Reddy S S.
Raloxifene causing malabsorption of levothyroxine.
Arch Intern Med.
2003;
163
1367-1370
- 16
Toft A D.
Thyroxine therapy.
New Engl J Med.
1994;
331
174-180
Dr. Alois Gessl
Clinical Division of Endocrinology and Metabolism
Department of Medicine III
Medical University of Vienna
Währinger Gürtel 18 - 20
1090 Vienna
Austria
eMail: alois.gessl@meduniwien.ac.at
